Annuncio • Apr 24
Shanghai Pret Composites Co., Ltd., Annual General Meeting, May 18, 2026 Shanghai Pret Composites Co., Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Annuncio • Mar 31
Shanghai Pret Composites Co., Ltd. to Report Q1, 2026 Results on Apr 25, 2026 Shanghai Pret Composites Co., Ltd. announced that they will report Q1, 2026 results on Apr 25, 2026 Annuncio • Dec 31
Shanghai Pret Composites Co., Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Shanghai Pret Composites Co., Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 Annuncio • Sep 30
Shanghai Pret Composites Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Shanghai Pret Composites Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annuncio • Jul 02
Shanghai Pret Composites Co., Ltd. to Report First Half, 2025 Results on Aug 22, 2025 Shanghai Pret Composites Co., Ltd. announced that they will report first half, 2025 results on Aug 22, 2025 Annuncio • Apr 22
Shanghai Pret Composites Co., Ltd. Proposes Final Cash Dividend for the Year 2024 Shanghai Pret Composites Co., Ltd. proposed final cash dividend/10 shares (tax included) of CNY 0.50000000 for the year 2024. Annuncio • Apr 20
Shanghai Pret Composites Co., Ltd., Annual General Meeting, May 12, 2025 Shanghai Pret Composites Co., Ltd., Annual General Meeting, May 12, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Annuncio • Mar 31
Shanghai Pret Composites Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025 Shanghai Pret Composites Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Annuncio • Dec 31
Shanghai Pret Composites Co., Ltd. to Report Fiscal Year 2024 Results on Apr 19, 2025 Shanghai Pret Composites Co., Ltd. announced that they will report fiscal year 2024 results on Apr 19, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.15 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.15 in 3Q 2023). Revenue: CN¥1.99b (down 19% from 3Q 2023). Net income: CN¥65.1m (down 68% from 3Q 2023). Profit margin: 3.3% (down from 8.2% in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Annuncio • Oct 17
Shanghai Pret Composites Co., Ltd. Announces Interim Cash Dividend Plan on A Shares, Payable on 22 October 2024 Shanghai Pret Composites Co., Ltd. announced interim cash dividend plan on A shares of CNY 0.20024500 per 10 shares (tax included) for 2024. Record date: 21 October 2024. Ex-date: 22 October 2024. Payment date: 22 October 2024. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥8.14, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Annuncio • Sep 30
Shanghai Pret Composites Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Shanghai Pret Composites Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥8.43, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. New Risk • Sep 07
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results. Reported Earnings • Aug 27
Second quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.10 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.10 in 2Q 2023). Revenue: CN¥1.80b (down 16% from 2Q 2023). Net income: CN¥65.6m (down 33% from 2Q 2023). Profit margin: 3.6% (down from 4.6% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Annuncio • Jun 29
Shanghai Pret Composites Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024 Shanghai Pret Composites Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024 Annuncio • Jun 20
Shanghai Pret Composites Co., Ltd. Announces Dividend on Share A for 2023, Payable on 25 June 2024 Shanghai Pret Composites Co., Ltd. announced Cash dividend/10 shares (tax included): CNY 0.50000000 on share A for 2023. Record date: 24 June 2024, Ex-date: 25 June 2024, Payment date: 25 June 2024. Reported Earnings • Apr 26
First quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.10 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥1.95b (up 2.0% from 1Q 2023). Net income: CN¥78.5m (down 24% from 1Q 2023). Profit margin: 4.0% (down from 5.4% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 24
Full year 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.20 in FY 2022) Full year 2023 results: EPS: CN¥0.45 (up from CN¥0.20 in FY 2022). Revenue: CN¥8.71b (up 29% from FY 2022). Net income: CN¥468.4m (up 132% from FY 2022). Profit margin: 5.4% (up from 3.0% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 37% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Annuncio • Apr 20
Shanghai Pret Composites Co., Ltd., Annual General Meeting, May 10, 2024 Shanghai Pret Composites Co., Ltd., Annual General Meeting, May 10, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥10.96, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 24% over the past three years. Annuncio • Mar 30
Shanghai Pret Composites Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Shanghai Pret Composites Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Reported Earnings • Mar 21
Full year 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.20 in FY 2022) Full year 2023 results: EPS: CN¥0.45 (up from CN¥0.20 in FY 2022). Revenue: CN¥8.71b (up 29% from FY 2022). Net income: CN¥465.3m (up 130% from FY 2022). Profit margin: 5.3% (up from 3.0% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 37% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥8.05, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 45% over the past three years. Valuation Update With 7 Day Price Move • Jan 10
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥10.99, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 34% over the past three years. Annuncio • Dec 30
Shanghai Pret Composites Co., Ltd. to Report Fiscal Year 2023 Results on Apr 19, 2024 Shanghai Pret Composites Co., Ltd. announced that they will report fiscal year 2023 results on Apr 19, 2024 Reported Earnings • Oct 24
Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.091 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.15 (up from CN¥0.091 in 3Q 2022). Revenue: CN¥2.45b (up 30% from 3Q 2022). Net income: CN¥200.8m (up 89% from 3Q 2022). Profit margin: 8.2% (up from 5.7% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.035 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.10 (up from CN¥0.035 in 2Q 2022). Revenue: CN¥2.14b (up 94% from 2Q 2022). Net income: CN¥97.8m (up 342% from 2Q 2022). Profit margin: 4.6% (up from 2.0% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 46% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Annuncio • May 17
Shanghai Pret Composites Co., Ltd. Announces Dividend on Share A for 2022, Payable on May 23, 2023 Shanghai Pret Composites Co., Ltd. announced Cash dividend/10 shares (tax included): CNY 0.50000000 on share A for 2022. Record date: 22 May 2023, Ex-date: 23 May 2023, Payment date: 23 May 2023. Reported Earnings • Apr 12
Full year 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.024 in FY 2021) Full year 2022 results: EPS: CN¥0.20 (up from CN¥0.024 in FY 2021). Revenue: CN¥6.76b (up 39% from FY 2021). Net income: CN¥202.1m (up CN¥178.3m from FY 2021). Profit margin: 3.0% (up from 0.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 41% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 4 experienced directors. No highly experienced directors. Chairman of the Supervisory Board Zhang Ying is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.002 loss in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.091 (up from CN¥0.002 loss in 3Q 2021). Revenue: CN¥1.88b (up 48% from 3Q 2021). Net income: CN¥106.3m (up CN¥108.3m from 3Q 2021). Profit margin: 5.7% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings. Reported Earnings • Aug 10
Second quarter 2022 earnings released: EPS: CN¥0.035 (vs CN¥0.013 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.035 (up from CN¥0.013 in 2Q 2021). Revenue: CN¥1.10b (up 1.2% from 2Q 2021). Net income: CN¥22.1m (up 80% from 2Q 2021). Profit margin: 2.0% (up from 1.1% in 2Q 2021). Over the next year, revenue is forecast to grow 8.4%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 51% per year, which means it is well ahead of earnings. Board Change • May 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Shijun Zhao was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.075 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.02 (down from CN¥0.075 in 1Q 2021). Revenue: CN¥1.30b (up 26% from 1Q 2021). Net income: CN¥24.4m (down 67% from 1Q 2021). Profit margin: 1.9% (down from 7.2% in 1Q 2021). Over the next year, revenue is forecast to grow 6.8%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Apr 27
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 3 experienced directors. 3 highly experienced directors. Chairman of the Board of Supervisors Qiao Sheng Ding is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Mar 15
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: CN¥0.024 (down from CN¥0.39 in FY 2020). Revenue: CN¥4.87b (up 9.5% from FY 2020). Net income: CN¥23.7m (down 94% from FY 2020). Profit margin: 0.5% (down from 8.9% in FY 2020). Revenue exceeded analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 7.3%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Oct 31
Third quarter 2021 earnings released: CN¥0.002 loss per share (vs CN¥0.081 profit in 3Q 2020) The company reported a soft third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.27b (up 13% from 3Q 2020). Net loss: CN¥2.03m (down 102% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 44% per year and the company’s share price has also increased by 44% per year. Reported Earnings • Aug 09
Second quarter 2021 earnings released: EPS CN¥0.013 (vs CN¥0.23 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.09b (down 18% from 2Q 2020). Net income: CN¥12.3m (down 95% from 2Q 2020). Profit margin: 1.1% (down from 17% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.063 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥1.03b (up 54% from 1Q 2020). Net income: CN¥74.2m (up 42% from 1Q 2020). Profit margin: 7.2% (down from 7.8% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 10
Full year 2020 earnings released: EPS CN¥0.47 (vs CN¥0.20 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.45b (up 24% from FY 2019). Net income: CN¥395.7m (up 140% from FY 2019). Profit margin: 8.9% (up from 4.6% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 04
Full year 2020 earnings released: EPS CN¥0.47 (vs CN¥0.20 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.46b (up 24% from FY 2019). Net income: CN¥400.5m (up 143% from FY 2019). Profit margin: 9.0% (up from 4.6% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Analyst Estimate Surprise Post Earnings • Mar 04
Revenue beats expectations Revenue exceeded analyst estimates by 8.2%. Over the next year, revenue is forecast to grow 7.8%, compared to a 51% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥20.23, the stock is trading at a trailing P/E ratio of 40.4x, up from the previous P/E ratio of 33.9x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 175%. Is New 90 Day High Low • Jan 07
New 90-day high: CN¥20.23 The company is up 37% from its price of CN¥14.78 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.85 per share. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥18.63, the stock is trading at a trailing P/E ratio of 37.2x, up from the previous P/E ratio of 32.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 150%. Is New 90 Day High Low • Dec 21
New 90-day high: CN¥16.26 The company is up 13% from its price of CN¥14.40 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.68 per share. Is New 90 Day High Low • Dec 05
New 90-day high: CN¥15.90 The company is up 11% from its price of CN¥14.28 on 04 September 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.48 per share. Is New 90 Day High Low • Nov 09
New 90-day high: CN¥15.52 The company is up 10.0% from its price of CN¥14.12 on 11 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.53 per share. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥418.5m, up 369% from the prior year. Total revenue was CN¥4.14b over the last 12 months, up 16% from the prior year.